Indolent systemic mastocytosis is a rare, chronic condition where abnormal mast cells—a type of white blood cell involved in allergic reactions—accumulate primarily in the bone marrow and sometimes in other organs like the skin. Most people with this condition live for many years with symptoms that can be challenging but are usually manageable with proper care and attention to triggers.

How Common Is Indolent Systemic Mastocytosis?

Indolent systemic mastocytosis, often shortened to ISM, represents the most common form of systemic mastocytosis, accounting for roughly 90 percent of all cases. Systemic mastocytosis as a whole is quite rare, with estimates suggesting it affects somewhere between 1 in 7,700 to 1 in 10,400 people in Europe. Worldwide, the condition is believed to occur in about 13 out of every 100,000 people, though these numbers may be underestimates because the disease often goes undiagnosed or misdiagnosed for years.^[1][2]

This diagnostic delay is significant. Research shows that many patients with systemic mastocytosis see multiple healthcare providers across different specialties before receiving a correct diagnosis. The average time from first symptoms to diagnosis can stretch from one to nine years, with a median delay of about three years. Some studies have found even longer delays, with one reporting an average of nearly five years from symptom onset to diagnosis. During this time, people often visit urgent care centers and emergency departments repeatedly without understanding the underlying cause of their distress.^[4][19]

Indolent systemic mastocytosis mainly affects adults and the elderly, with onset typically occurring in adulthood. Unlike some forms of mastocytosis that primarily affect children and involve only the skin, ISM is a condition that persists throughout a person’s life. The good news is that people with indolent systemic mastocytosis generally have a normal or nearly normal life expectancy, distinguishing it from more aggressive forms of the disease.^[1][4]

What Causes This Condition?

The root cause of indolent systemic mastocytosis lies in a genetic mutation that occurs in the body’s cells. Although the exact reason why this mutation develops is not fully understood, scientists have identified that nearly all people with ISM carry a specific genetic change called the KIT D816V mutation. This mutation affects a gene that produces a protein responsible for controlling the growth and survival of mast cells.^[1][3]

To understand what goes wrong, it helps to think of the KIT protein as a switch that can be turned on and off to regulate mast cell production. The KIT D816V mutation essentially keeps this switch stuck in the “on” position, causing mast cells to grow and multiply continuously when they should not. This uncontrolled proliferation leads to an abnormal accumulation of these cells in various tissues and organs throughout the body.^[3]

In some individuals, this mutation is found only in the mast cells themselves. In other cases, the mutation can be detected in additional blood cells, including basophils (another type of white blood cell), eosinophils, neutrophils, and even immune cells called B- and T-lymphocytes. When the mutation is found in early stem cells that give rise to multiple cell types, it suggests that the genetic change occurred very early in the development of the blood-forming system. This can mean the mutation affects not just mast cells but potentially other cell lines as well.^[1]

The condition is not typically inherited from parents. In the vast majority of cases, the KIT mutation happens spontaneously for no apparent reason during a person’s lifetime. Only in very rare instances does mastocytosis appear to run in families, suggesting that most cases arise from random genetic changes rather than being passed down through generations.^[5]

Who Is Most at Risk?

Because the KIT D816V mutation appears to occur randomly in most cases, there are no clear risk factors that predict who will develop indolent systemic mastocytosis. The condition is not linked to lifestyle choices, environmental exposures, or behaviors that people can change. It simply happens as a result of an unpredictable genetic change in the body’s cells.^[1][5]

However, certain groups may be more vulnerable to severe complications once they have the disease. People with ISM face a significantly elevated risk of developing severe anaphylactic reactions—life-threatening allergic responses that can cause cardiovascular collapse and death. This heightened risk exists because the abnormally high number of mast cells in the body can release massive amounts of chemical mediators like histamine all at once when triggered. This is particularly concerning for individuals who are exposed to insect stings, especially from bees and wasps, which are among the most common triggers for anaphylaxis in people with mastocytosis.^[1][3]

Additionally, people with indolent systemic mastocytosis may be at risk for developing severe osteoporosis, a condition where bones become weak and brittle. In some cases, this bone weakening can be so severe that it leads to spontaneous fractures—breaks that occur without any obvious injury or trauma. The exact mechanism by which abnormal mast cells affect bone health is not fully understood, but it is thought that the chemicals released by these cells may interfere with normal bone remodeling processes.^[1]

While indolent systemic mastocytosis itself is considered a relatively stable condition, there is a small possibility of progression to more aggressive forms of the disease. Studies suggest that approximately 3 to 4 percent of people with ISM may eventually develop advanced systemic mastocytosis, which involves more severe organ damage and complications. However, the vast majority of individuals with ISM remain in the indolent category throughout their lives.^[7][19]

What Symptoms Should You Watch For?

The symptoms of indolent systemic mastocytosis can vary widely from person to person, but they generally fall into two main categories: those caused by mast cell accumulation in tissues and those caused by the release of chemical mediators from these cells. Because mast cells gather primarily in the bone marrow and often in the skin, many people with ISM develop visible skin changes alongside other systemic symptoms.^[1][2]

Skin symptoms are very common in indolent systemic mastocytosis. The most typical presentation is a condition called urticaria pigmentosa, which appears as reddish-brown spots, bumps, or patches on the skin. These lesions may be itchy and can become more noticeable when rubbed or stroked—a phenomenon known as Darier’s sign. When the affected skin is irritated, it may turn red, swell, or develop hives. Not everyone with ISM has skin lesions, however. Some people have a subtype called isolated bone marrow mastocytosis, where mast cells accumulate primarily in the bone marrow without causing visible skin changes.^[1][5]

Beyond skin changes, many people with ISM experience a range of symptoms related to the release of histamine and other inflammatory chemicals from mast cells. These symptoms often mimic allergic reactions and can include intense itching all over the body, flushing of the skin, headaches, dizziness, and episodes of fainting or near-fainting called syncope. Some individuals describe feeling lightheaded or experiencing a sudden drop in blood pressure when symptoms flare.^[1][6]

Gastrointestinal symptoms are also frequent and can be particularly bothersome. People may experience nausea, vomiting, diarrhea, and abdominal cramping or pain. These digestive issues occur because mast cells accumulate in the lining of the stomach and intestines, releasing chemicals that irritate the digestive tract. Some individuals develop stomach ulcers as a result of excessive acid production triggered by histamine release.^[1][6]

Musculoskeletal symptoms, including bone pain and joint discomfort, affect some people with ISM. This pain may be related to the presence of mast cells in the bone marrow and their effects on bone structure. Fatigue is another common complaint, with many individuals reporting persistent tiredness that interferes with daily activities.^[2][17]

Cognitive and emotional symptoms can also occur. Some people with indolent systemic mastocytosis report difficulties with concentration and memory, sometimes described as “brain fog.” Mood changes, including depression and anxiety, are not uncommon. These neuropsychiatric symptoms may be related to the effects of inflammatory mediators on the brain, though the exact mechanisms are still being studied.^[1][7]

Perhaps one of the most concerning aspects of ISM is the risk of severe anaphylaxis. This is a medical emergency that can occur when mast cells release large amounts of mediators all at once. Symptoms of anaphylaxis include difficulty breathing, rapid heartbeat called palpitations, severe drop in blood pressure, swelling of the throat or tongue, and loss of consciousness. Anaphylaxis can be triggered by various factors, and without immediate treatment with epinephrine, it can be fatal.^[3][8]

Symptoms often come and go in episodes. People with ISM may have periods where they feel relatively well, followed by “flares” or “attacks” where multiple symptoms appear suddenly and severely. Recognizing the specific triggers that cause these flares is an important part of managing the condition.^[2][6]

Can Indolent Systemic Mastocytosis Be Prevented?

Unfortunately, because indolent systemic mastocytosis results from a spontaneous genetic mutation that occurs randomly, there is no known way to prevent the condition from developing in the first place. The mutation happens at the cellular level for reasons that are not yet fully understood, and there are no lifestyle modifications, dietary changes, or preventive measures that can stop it from occurring.^[1][5]

However, while the disease itself cannot be prevented, people diagnosed with ISM can take important steps to prevent symptom flares and life-threatening complications. A critical part of prevention involves identifying and avoiding personal triggers that cause mast cells to release their chemical mediators. Common triggers include alcohol consumption, spicy foods, temperature changes (both heat and cold), emotional stress, physical exertion, certain medications, and insect stings. Each person with ISM may have different triggers, so keeping a symptom diary can help identify specific patterns.^[6][7]

All individuals with indolent systemic mastocytosis should carry injectable epinephrine at all times. Epinephrine is the first-line treatment for anaphylaxis, and having it readily available can be lifesaving. Patients should be trained on how and when to use their epinephrine auto-injector, and family members or close contacts should also be educated on how to administer it in an emergency. After using epinephrine, immediate medical attention is still necessary, as additional treatment may be required.^[8][14]

For people with ISM who have documented allergies to insect venom, a preventive treatment called venom immunotherapy is highly recommended. This involves receiving regular injections of small amounts of venom to help the body build tolerance and reduce the severity of reactions if stung again. Venom immunotherapy has been shown to be effective in reducing the risk of life-threatening anaphylaxis in people with mastocytosis who are allergic to bee or wasp stings.^[8]

Bone health should also be monitored and protected in people with ISM. Because the condition can lead to osteoporosis, regular bone density testing may be recommended. Preventive measures to maintain bone strength include ensuring adequate intake of calcium and vitamin D, engaging in weight-bearing exercise as tolerated, and avoiding smoking and excessive alcohol consumption. In some cases, medications called bisphosphonates may be prescribed to help strengthen bones and prevent fractures.^[5][11]

How the Body Changes in Indolent Systemic Mastocytosis

Understanding what happens inside the body with indolent systemic mastocytosis requires knowing what mast cells normally do and how their function becomes problematic in this condition. Mast cells are part of the immune system and play an important role in defending the body against infections, particularly parasites. They are stationed throughout the body’s tissues, especially in areas that interface with the external environment, such as the skin, the lining of the airways, and the digestive tract.^[3][8]

When mast cells detect a threat—such as an allergen or a pathogen—they release stored granules containing powerful chemical mediators. The most well-known of these mediators is histamine, but mast cells also release tryptase, leukotrienes, prostaglandins, and various other substances. These chemicals trigger an inflammatory response that includes increased blood flow to the area (causing redness and warmth), increased vascular permeability (causing swelling), and stimulation of nerve endings (causing itching and pain). In a normal immune response, this reaction is controlled and temporary, helping the body fight off infection or injury.^[3][9]

In indolent systemic mastocytosis, several abnormal processes occur simultaneously. First, because of the KIT D816V mutation, mast cells proliferate excessively and accumulate in various organs and tissues, particularly the bone marrow. These abnormal mast cells also tend to live longer than normal mast cells, further contributing to their accumulation. Second, these mast cells are more easily activated than normal ones, meaning they release their chemical mediators more readily in response to triggers that would not normally cause such a strong reaction. Third, because there are so many more mast cells present, even a normal level of activation can result in the release of excessive amounts of mediators into the bloodstream and surrounding tissues.^[3][8]

The excessive and inappropriate release of mediators explains most of the symptoms experienced by people with ISM. When histamine is released in large quantities, it binds to receptors throughout the body. In the skin, this causes flushing, itching, and hives. In the blood vessels, it causes dilation and increased permeability, which can lead to dangerously low blood pressure. In the digestive tract, histamine stimulates acid production and triggers nausea, vomiting, and diarrhea. In the brain, it may contribute to headaches, cognitive difficulties, and mood changes.^[6][8]

The physical presence of mast cells infiltrating tissues also causes problems. In the bone marrow, large numbers of mast cells can disrupt normal blood cell production, though this is more common in advanced forms of mastocytosis. The accumulation of mast cells in bones can also affect bone remodeling—the normal process by which old bone is broken down and new bone is formed. When this process is disrupted, bones can become weak and prone to fracture. In the skin, clusters of mast cells create the visible lesions characteristic of urticaria pigmentosa.^[1][10]

One of the defining features that distinguishes indolent systemic mastocytosis from more aggressive forms is the absence of significant organ dysfunction. People with ISM do not have what doctors call “C-findings”—signs of organ damage that would indicate the disease is causing tissues and organs to fail. They also do not have “B-findings,” which are markers suggesting the disease might be progressing toward a more aggressive form. The presence of neither B-findings nor C-findings is what keeps ISM in the indolent category and is associated with a much better long-term outlook.^[1][10]

Interestingly, the abnormal mast cells in ISM also carry antibodies on their surface. These antibodies, called IgE, bind to allergens and trigger the release of mediators. This is why people with mastocytosis can have both the chronic symptoms of the disease and acute allergic reactions to specific substances. The interaction between IgE, allergens, and the oversensitive mast cells in mastocytosis creates a perfect storm for severe anaphylactic reactions, particularly to insect venom.^[3][9]

Blood tests in people with ISM often show elevated levels of tryptase, a protein that is stored in mast cell granules and released along with histamine. Measuring serum tryptase levels is a useful diagnostic tool because persistently elevated levels suggest an increased number of mast cells in the body. However, some people with isolated bone marrow mastocytosis may have only slightly elevated or even normal tryptase levels, which can make diagnosis more challenging.^[1][10]